BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Banerjee T, Aggarwal M, Sommers JA, Brosh RM Jr. Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors. Methods 2016;108:130-41. [PMID: 27064001 DOI: 10.1016/j.ymeth.2016.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Cao Y, Luo C, Yang P, Li P, Wu C. Indazole scaffold: a generalist for marketed and clinical drugs. Med Chem Res 2021;30:501-18. [DOI: 10.1007/s00044-020-02665-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lodovichi S, Cervelli T, Pellicioli A, Galli A. Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach. Int J Mol Sci 2020;21:E6684. [PMID: 32932697 DOI: 10.3390/ijms21186684] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Datta A, Brosh RM Jr. New Insights Into DNA Helicases as Druggable Targets for Cancer Therapy. Front Mol Biosci 2018;5:59. [PMID: 29998112 DOI: 10.3389/fmolb.2018.00059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
4 Awate S, Brosh RM Jr. Interactive Roles of DNA Helicases and Translocases with the Single-Stranded DNA Binding Protein RPA in Nucleic Acid Metabolism. Int J Mol Sci 2017;18:E1233. [PMID: 28594346 DOI: 10.3390/ijms18061233] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
5 Brosh RM Jr. Special Methods collection on DNA helicases. Methods 2016;108:1-3. [PMID: 27565743 DOI: 10.1016/j.ymeth.2016.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Vallamkondu J, John A, Wani WY, Ramadevi SP, Jella KK, Reddy PH, Kandimalla R. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets. Biochim Biophys Acta Mol Basis Dis 2020;1866:165889. [PMID: 32603829 DOI: 10.1016/j.bbadis.2020.165889] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
7 Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, Kumar S, Bhattacharyya A, Kumar H, Bansal S, Medhi B. Drug targets for corona virus: A systematic review. Indian J Pharmacol 2020;52:56-65. [PMID: 32201449 DOI: 10.4103/ijp.IJP_115_20] [Cited by in Crossref: 172] [Cited by in F6Publishing: 117] [Article Influence: 86.0] [Reference Citation Analysis]
8 Jo U, Murai Y, Takebe N, Thomas A, Pommier Y. Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11. Cancers (Basel) 2021;13:4601. [PMID: 34572827 DOI: 10.3390/cancers13184601] [Reference Citation Analysis]
9 Datta A, Brosh RM Jr. WRN rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancer. Bioessays 2022;:e2200057. [PMID: 35751457 DOI: 10.1002/bies.202200057] [Reference Citation Analysis]
10 Sommers JA, Kulikowicz T, Croteau DL, Dexheimer T, Dorjsuren D, Jadhav A, Maloney DJ, Simeonov A, Bohr VA, Brosh RM Jr. A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN). PLoS One 2019;14:e0210525. [PMID: 30625228 DOI: 10.1371/journal.pone.0210525] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
11 Orlovetskie N, Serruya R, Abboud-Jarrous G, Jarrous N. Targeted inhibition of WRN helicase, replication stress and cancer. Biochim Biophys Acta Rev Cancer 2017;1867:42-8. [PMID: 27902925 DOI: 10.1016/j.bbcan.2016.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]